Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06936696 · ClinicalTrials.gov registry record · NA
Project PAIR: Parent-implemented Articulation Intervention With Recast
A NA study of Hearing Impaired Children, sponsored by Vanderbilt University.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT06936696: Recruiting NA study of Hearing Impaired Children, sponsored by Vanderbilt University.
NCT06936696 is a NA study of Hearing Impaired Children that is actively recruiting participants, run by Vanderbilt University. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06936696, a NA study of Hearing Impaired Children, is actively recruiting participants, sponsored by Vanderbilt University.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
Using a single-case multiple baseline across participants design, this study aims to explore the effectiveness of parent-implemented Broad Treatment Speech Recast supplemented with traditional clinician-led articulation therapy on speech production in elementary-aged deaf and hard of hearing children. To address these objectives, the following research questions will be investigated: 1. Does drill-based articulation therapy, administered by a speech-language pathologist, improve speech sound production in DHH children when parent-implemented BTSR is concurrently utilized at home? 2. Does the combination of parent-implemented BTSR and clinician-led traditional articulation therapy result in generalization of speech sound accuracy at the conversation level?
Primary Outcome
The percent of accurate phoneme productions per target, which is derived by dividing the number of correct productions by the total possible points for each target and then multiplying by 100. Accurate phoneme production is defined by a speech-language pathologist's judgment of perceptual accuracy through the lens of broad transcription.
Conditions Studied
Interventions
- BEHAVIORAL Broad Target Speech Recast
- BEHAVIORAL Traditional Speech Therapy
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-06-10 |
| Est. Completion | 2026-08 |
| Phase | NA |
What NCT06936696 shows while recruiting
NCT06936696 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Hearing Impaired Children appearing as the primary indexed condition, and to 2 interventions - of which Broad Target Speech Recast is the first listed.
NCT06936696 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT06936696 about?
NCT06936696 is a clinical study titled "Project PAIR: Parent-implemented Articulation Intervention With Recast". Using a single-case multiple baseline across participants design, this study aims to explore the effectiveness of parent-implemented Broad Treatment Speech Recast supplemented with traditional clinician-led articulation therapy on speech production in elementary-aged deaf and hard of hearing childre...
What is the current status of trial NCT06936696?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2025-06-10. Estimated completion is 2026-08.
What conditions does trial NCT06936696 study?
This clinical trial studies the following conditions: Hearing Impaired Children.
What interventions are being tested in trial NCT06936696?
The interventions under investigation include: Broad Target Speech Recast (BEHAVIORAL), Traditional Speech Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT06936696?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06936696 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06936696's enrollment target sits among peer trials
10 1928th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI